PER 13.0% 13.0¢ percheron therapeutics limited

Ann: Funding for ATL1103 Phase II Trial and Pipel, page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 3,115 Posts.
    lightbulb Created with Sketch. 615
    re: Ann: Funding for ATL1103 Phase II Trial a... Would be very nice to see gains here on ANP like PRR saw, then look at it proportionally to number of products and value or gains in the product and we could easily be sitting on a multi multi bagger.

    Go ANP, its only a matter of time for us IMO.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
13.0¢
Change
0.015(13.0%)
Mkt cap ! $117.2M
Open High Low Value Volume
12.0¢ 13.5¢ 12.0¢ $612.7K 4.843M

Buyers (Bids)

No. Vol. Price($)
2 56662 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
13.5¢ 600000 2
View Market Depth
Last trade - 16.10pm 11/10/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.